Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.03
+0.34 (1.38%)
At close: Nov 26, 2025, 4:00 PM EST
25.05
+0.02 (0.08%)
After-hours: Nov 26, 2025, 7:31 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.47 billion as of November 26, 2025. Its market cap has increased by 2.26% in one year.
Market Cap
2.47B
Enterprise Value
1.55B
1-Year Change
2.26%
Ranking
Category
Stock Price
$25.03
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.47B, an increase of 653.20%. That is a compound annual growth rate of 41.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 2.47B | 25.15% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |